ArticleBrain communications2022

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study.

Féline E V Scheijmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.